Senators challenged Kennedy, who was nominated as health secretary by President Trump, on his long track record of ...

States and providers regained access to a key healthcare payments portal late Tuesday amid pushback over the Trump ...

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...

BioAge scrapped the drug at the center of its $198 million initial public offering last year. Elsewhere, Akero and 89bio ...

The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...